Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cellibre
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cellibre

Cellibre

Series A

Cellibre: A cellular agriculture firm transforming cells into sustainable, large-scale product factories.

HQ
San Diego, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize manufacturing through cellular agriculture, Cellibre transforms cells into specialized, sustainable factories for large-scale production of essential goods. The company leverages advanced strain engineering, biochemistry, and precision fermentation to create eco-friendly alternatives to traditional manufacturing processes. Their market focus includes industries such as pharmaceuticals, cosmetics, and food, aiming to provide sustainable solutions that reduce environmental impact.

Notable figures associated with Cellibre include experts in biotechnology and sustainable manufacturing. The company has attracted significant investment from venture capital firms interested in green technology and innovation. Key achievements include the successful development of proprietary strains and processes that have demonstrated the potential to scale sustainably. Cellibre's impact is marked by its contribution to reducing the carbon footprint of manufacturing and promoting a more sustainable future through cutting-edge biological engineering.

Cellibre - Similar Companies

Celltheon logo

Celltheon

celltheon.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Cellares logo

Cellares

cellares.com

Cellaria logo

Cellaria

cellariabio.com

Colorado Biofactory logo

Colorado Biofactory

Cellular Approaches logo

Cellular Approaches

Liberation Labs logo

Liberation Labs

liberationlabs.com

Celldom logo

Celldom

celldom.com

RoosterBio logo

RoosterBio

Celularity logo

Celularity

celularity.com

Cellino logo

Cellino

cellinobio.com

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

New Agrarian logo

New Agrarian

Spheringenics logo

Spheringenics

NouBio logo

NouBio

noubio.co

Cellibre - Quick Facts

Who are Cellibre's competitors?

Companies similar to Cellibre include Celltheon, Cell BioEngines, Cellares and Cellaria.

When was Cellibre founded?

Cellibre was founded in 2017.

Where is Cellibre's headquarters located?

Cellibre's headquarters is located in San Diego, CA, US.

When was Cellibre's last funding round?

Cellibre's most recent funding round was for $11.5M (USD) in October 2021.

How much has Cellibre raised to-date?

As of Oct 13, 2021, Cellibre has raised a total of $11.5M (USD).

How many employees does Cellibre have?

Cellibre has 30 employees as of Feb 5, 2024.

Cellibre - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Agriculture
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bio-Manufactured Products
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified